Knockdown of A-kinase anchor protein 4 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/β-catenin pathway in human gastric cancer cells

Journal of Cellular Biochemistry
Quanying LiChangjiang Qin

Abstract

Hypoxia induces epithelial-mesenchymal transition (EMT) in tumorigenesis. A-kinase anchor protein 4 (AKAP4) is a member of AKAPs family and plays a critical role in tumorigenesis. However, the biological role of AKAP4 in gastric cancer remains unknown. Thus, we investigated the effect of AKAP4 on EMT in human gastric cancer cells under hypoxic conditions. Our results showed that AKAP4 expression was significantly upregulated in human gastric cancer cell lines. In addition, silenced expression of hypoxia-inducible factor-1α markedly suppressed AKAP4 expression in gastric cancer cells under hypoxia. Furthermore, knockdown of AKAP4 significantly prevented hypoxia-induced migration, invasion, and EMT process in gastric cancer cells. Mechanistically, knockdown of AKAP4 prevented the activation of the Wnt/β-catenin pathway in gastric cancer cells under hypoxia condition. These findings indicate that knockdown of AKAP4 inhibits hypoxia-induced EMT in human gastric cancer cells, at least in part, via inactivation of the Wnt/β-catenin signaling pathway. It is, therefore, AKAP4 may be a potential therapeutic target for the treatment of gastric cancer.

References

Jun 4, 1999·Trends in Cell Biology·M Colledge, J D Scott
Feb 22, 2001·Journal of the National Cancer Institute·M Höckel, P Vaupel
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Apr 6, 2004·Methods in Enzymology·Peter VaupelMichael Höckel
Jul 8, 2008·Acta Biochimica Et Biophysica Sinica·Yadi Wu, Binhua P Zhou
Jan 24, 2009·Acta histochemica·Susan A BrooksDebbie M S Hall
Jun 3, 2009·The Journal of Clinical Investigation·Raghu Kalluri
Jul 25, 2009·Lancet·Henk H HartgrinkCornelis J H van de Velde
Nov 9, 2012·Digestive Diseases and Sciences·Lang ZhaZiwei Wang
Jan 21, 2015·Technology in Cancer Research & Treatment·Jinbao GuoWeidong Lu
Jul 15, 2015·Oncotarget·Kiranmai GumireddyQihong Huang
Nov 23, 2015·Journal of Experimental & Clinical Cancer Research : CR·Nirmala JagadishAnil Suri
Dec 4, 2015·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·L MaranoF Roviello
Dec 9, 2015·Biochimica Et Biophysica Acta·Dario DivianiDarko Maric
Feb 14, 2016·Investigational New Drugs·Gianluca TomaselloRodolfo Passalacqua
Mar 1, 2016·Oncogene·E W LinA K Rustgi
May 4, 2016·Pharmacology & Therapeutics·Caroline WigerupDaniel Bexell
Aug 30, 2016·World Journal of Gastroenterology : WJG·Daniela Cornelia LazărAdrian Goldiş
Jul 18, 2017·Oncology Reports·Chun-Fu HongCheng-Wen Wu
Sep 21, 2017·Cellular Signalling·Erica Reggi, Dario Diviani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.